Type |
Details |
Score |
Strain |
Attribute String: |
congenic, mutant strain, transgenic |
|
•
•
•
•
•
|
Allele |
Name: |
gene trap ROSA 26, Philippe Soriano; targeted mutation 1, Maike Buchner |
Allele Type: |
Targeted |
Attribute String: |
Conditional ready, Humanized sequence, Inserted expressed sequence |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Myh6-Akt1*T308D*S473D)1Siz/? |
Background: |
Not Specified |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Myh6-Akt1)564Anr/? |
Background: |
involves: C57BL/6 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Myh6-Akt1)20Anr/? |
Background: |
involves: C57BL/6 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Myh6-Akt1)20Anr/? |
Background: |
involves: C57BL/6 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Lck-Akt1*E40K)E-3Pnt/? |
Background: |
involves: C3H/He * C57BL/6 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Lck-Akt1*E40K)E-3Pnt/? |
Background: |
Not Specified |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Ins2-Akt1*)3Mbb/? |
Background: |
involves: C57BL/6 * SJL |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Ins2-Akt1*)3Mbb/? |
Background: |
B6.Cg-Tg(Ins2-Akt1*)3Mbb |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Smithson LJ |
Year: |
2016 |
Journal: |
Genes Dev |
Title: |
Proteomic analysis reveals GIT1 as a novel mTOR complex component critical for mediating astrocyte survival. |
Volume: |
30 |
Issue: |
12 |
Pages: |
1383-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wittenberg AD |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
Phosphorylated Ribosomal Protein S6 Is Required for Akt-Driven Hyperplasia and Malignant Transformation, but Not for Hypertrophy, Aneuploidy and Hyperfunction of Pancreatic β-Cells. |
Volume: |
11 |
Issue: |
2 |
Pages: |
e0149995 |
|
•
•
•
•
•
|
Publication |
First Author: |
Elghazi L |
Year: |
2008 |
Journal: |
Genesis |
Title: |
Generation of a reporter mouse line expressing Akt and EGFP upon Cre-mediated recombination. |
Volume: |
46 |
Issue: |
5 |
Pages: |
256-64 |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
451
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Publication |
First Author: |
Fatrai S |
Year: |
2006 |
Journal: |
Diabetes |
Title: |
Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2, and p21 levels and cyclin-dependent kinase-4 activity. |
Volume: |
55 |
Issue: |
2 |
Pages: |
318-25 |
|
•
•
•
•
•
|
Allele |
Name: |
transgene insertion 4-1, Pamela Ohashi |
Allele Type: |
Transgenic |
Attribute String: |
Constitutively active, Inserted expressed sequence |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Lck-Akt1*)M-1Pnt/? |
Background: |
involves: C3H/He * C57BL/6 |
Zygosity: |
ot |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tcra/Tcra Tg(Lck-Akt1*E40K)E-3Pnt/? |
Background: |
involves: 129S2/SvPas * C3H/He * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdk6/Cdk6 Tg(Lck-Akt1*E40K)E-3Pnt/? |
Background: |
involves: 129S4/SvJae |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Cdk6/Cdk6<+> Tg(Lck-Akt1*E40K)E-3Pnt/? |
Background: |
involves: 129S4/SvJae |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Toker A |
Year: |
2015 |
Journal: |
Cancer Cell |
Title: |
PIPPing on AKT1: How Many Phosphatases Does It Take to Turn off PI3K? |
Volume: |
28 |
Issue: |
2 |
Pages: |
143-5 |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
Protein kinase B (PKB), also called Akt or RAC, is a phosphatidylinositol 3'-kinase (PI3K)-dependent Ser/Thr kinase which alters the activity of the targeted protein []. Akt regulates numerous cellular processes, including cell growth, differentiation, proliferation, apoptosis, and glucose metabolism. Among its many roles, Akt appears to be common to signaling pathways that mediate the metabolic effects of insulin in several physiologically important target tissues [, ]. Human Akt has three isoforms derived for distinct genes: Akt1/PKBalpha, Akt2/PKBbeta, and Akt3/PKBgamma.This entry includes the isoforms alpha. Akt1 and Akt2 have distinct functions; they are involved in the control of growth and metabolism, respectively [, ]. |
|
•
•
•
•
•
|
Protein Coding Gene |
Type: |
protein_coding_gene |
Organism: |
mouse, laboratory |
|
•
•
•
•
•
|
Protein |
Organism: |
Mus musculus/domesticus |
Length: |
913
 |
Fragment?: |
false |
|
•
•
•
•
•
|
Strain |
Attribute String: |
congenic, mutant strain, targeted mutation, transgenic |
|
•
•
•
•
•
|
Publication |
First Author: |
O'Donnell RK |
Year: |
2013 |
Journal: |
PLoS One |
Title: |
Overexpression of MyrAkt1 in endothelial cells leads to erythropoietin- and BMP4-independent splenic erythropoiesis in mice. |
Volume: |
8 |
Issue: |
1 |
Pages: |
e55095 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(Myh6-Akt1*T308D*S473D)1Siz/? Tg(Myh6-Pik3ca)1Siz/? |
Background: |
involves: FVB/N |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rag2/Rag2 Tg(Lck-Akt1*)M-1Pnt/? |
Background: |
involves: 129S/SvEv * C3H/He * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rag1/Rag1 Tg(Lck-Akt1*E40K)E-3Pnt/? |
Background: |
involves: 129S7/SvEvBrd * C3H/He * C57BL/6 |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rps6kb1/Rps6kb1 Tg(Ins2-Akt1*)3Mbb/? |
Background: |
B6.Cg-Rps6kb1 Tg(Ins2-Akt1*)3Mbb |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rps6kb2/Rps6kb2 Tg(Ins2-Akt1*)3Mbb/? |
Background: |
B6.Cg-Rps6kb2 Tg(Ins2-Akt1*)3Mbb |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(CAG-lacZ,-Akt1*,-EGFP)56Ebm/? Tg(Ins2-cre)23Herr/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6J * CBA/J |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(CAG-lacZ,-Akt1*,-EGFP)56Ebm/? Tg(Ela1-cre)16Eps/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
HT Experiment |
Series Id: |
GSE11662 |
Experiment Type: |
transcription profiling by array |
Study Type: |
WT vs. Mutant |
Source: |
ArrayExpress |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Domain |
Description: |
This entry represents the phosphatase domain found in PTEN, which is a magnesium-dependent bifunctional phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase/dual-specificity protein phosphatase PTEN (; ; ), which possesses the following catalytic activities:Phosphatidylinositol 3,4,5-trisphosphate + H(2)O = phosphatidylinositol 4,5-bisphosphate + phosphate.A phosphoprotein + H(2)O = a protein + phosphate.Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate.This protein acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine-phosphorylated proteins []. It also acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4-diphosphate, phosphatidylinositol 3-phosphate and inositol 1,3,4,5-tetrakisphosphate. The lipid phosphatase activity is critical for its tumour suppressor function []. PTEN antagonizes the PI3K-AKT/PKB signalling pathway by dephosphorylating phosphoinositides and thereby modulating cell cycle progression and cell survival. The unphosphorylated form of PTEN cooperates with AIP1 to suppress AKT1 activation. PTEN dephosphorylates tyrosine-phosphorylated focal adhesion kinase and inhibits cell migration and integrin-mediated cell spreading and focal adhesion form []. |
|
•
•
•
•
•
|
Protein Domain |
Type: |
Family |
Description: |
This entry represents the magnesium-dependent bifunctional phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase/dual-specificity protein phosphatase PTEN (; ; ), which possesses the following catalytic activities:Phosphatidylinositol 3,4,5-trisphosphate + H(2)O = phosphatidylinositol 4,5-bisphosphate + phosphate.A phosphoprotein + H(2)O = a protein + phosphate.Protein tyrosine phosphate + H(2)O = protein tyrosine + phosphate.This protein acts as a dual-specificity protein phosphatase, dephosphorylating tyrosine-, serine- and threonine-phosphorylated proteins []. It also acts as a lipid phosphatase, removing the phosphate in the D3 position of the inositol ring from phosphatidylinositol 3,4,5-trisphosphate, phosphatidylinositol 3,4-diphosphate, phosphatidylinositol 3-phosphate and inositol 1,3,4,5-tetrakisphosphate. The lipid phosphatase activity is critical for its tumour suppressor function []. PTEN antagonizes the PI3K-AKT/PKB signalling pathway by dephosphorylating phosphoinositides and thereby modulating cell cycle progression and cell survival. The unphosphorylated form of PTEN cooperates with AIP1 to suppress AKT1 activation. PTEN dephosphorylates tyrosine-phosphorylated focal adhesion kinase and inhibits cell migration and integrin-mediated cell spreading and focal adhesion form []. |
|
•
•
•
•
•
|
Publication |
First Author: |
Xiao Y |
Year: |
2007 |
Journal: |
Cell Signal |
Title: |
PTEN catalysis of phospholipid dephosphorylation reaction follows a two-step mechanism in which the conserved aspartate-92 does not function as the general acid--mechanistic analysis of a familial Cowden disease-associated PTEN mutation. |
Volume: |
19 |
Issue: |
7 |
Pages: |
1434-45 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yin Y |
Year: |
2008 |
Journal: |
Oncogene |
Title: |
PTEN: a new guardian of the genome. |
Volume: |
27 |
Issue: |
41 |
Pages: |
5443-53 |
|
•
•
•
•
•
|
Publication |
First Author: |
Degtyarev M |
Year: |
2008 |
Journal: |
J Cell Biol |
Title: |
Akt inhibition promotes autophagy and sensitizes PTEN-null tumors to lysosomotropic agents. |
Volume: |
183 |
Issue: |
1 |
Pages: |
101-16 |
|
•
•
•
•
•
|
Publication |
First Author: |
Phung TL |
Year: |
2007 |
Journal: |
Cancer Res |
Title: |
Endothelial Akt signaling is rate-limiting for rapamycin inhibition of mouse mammary tumor progression. |
Volume: |
67 |
Issue: |
11 |
Pages: |
5070-5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ecker V |
Year: |
2021 |
Journal: |
Nat Commun |
Title: |
Targeted PI3K/AKT-hyperactivation induces cell death in chronic lymphocytic leukemia. |
Volume: |
12 |
Issue: |
1 |
Pages: |
3526 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hutchinson JN |
Year: |
2004 |
Journal: |
Cancer Res |
Title: |
Activation of Akt-1 (PKB-alpha) can accelerate ErbB-2-mediated mammary tumorigenesis but suppresses tumor invasion. |
Volume: |
64 |
Issue: |
9 |
Pages: |
3171-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Malstrom S |
Year: |
2001 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Tumor induction by an Lck-MyrAkt transgene is delayed by mechanisms controlling the size of the thymus. |
Volume: |
98 |
Issue: |
26 |
Pages: |
14967-72 |
|
•
•
•
•
•
|
Publication |
First Author: |
Parsons MJ |
Year: |
2001 |
Journal: |
J Immunol |
Title: |
Expression of active protein kinase B in T cells perturbs both T and B cell homeostasis and promotes inflammation. |
Volume: |
167 |
Issue: |
1 |
Pages: |
42-8 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Rps6kb1/Rps6kb1 Rps6kb2/Rps6kb2 Tg(Ins2-Akt1*)3Mbb/? |
Background: |
involves: 129P2/OlaHsd * C57BL/6 * SJL |
Zygosity: |
cx |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(CAG-lacZ,-Akt1*,-EGFP)56Ebm/? Tg(Pdx1-cre)89.1Dam/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Lee JK |
Year: |
2016 |
Journal: |
Cancer Cell |
Title: |
N-Myc Drives Neuroendocrine Prostate Cancer Initiated from Human Prostate Epithelial Cells. |
Volume: |
29 |
Issue: |
4 |
Pages: |
536-547 |
|
•
•
•
•
•
|
Publication |
First Author: |
Cho H |
Year: |
2001 |
Journal: |
Science |
Title: |
Insulin resistance and a diabetes mellitus-like syndrome in mice lacking the protein kinase Akt2 (PKB beta). |
Volume: |
292 |
Issue: |
5522 |
Pages: |
1728-31 |
|
•
•
•
•
•
|
Publication |
First Author: |
Varga J |
Year: |
2020 |
Journal: |
J Exp Med |
Title: |
AKT-dependent NOTCH3 activation drives tumor progression in a model of mesenchymal colorectal cancer. |
Volume: |
217 |
Issue: |
10 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Lee DY |
Year: |
2010 |
Journal: |
Genes Dev |
Title: |
Neurofibromatosis-1 regulates neuroglial progenitor proliferation and glial differentiation in a brain region-specific manner. |
Volume: |
24 |
Issue: |
20 |
Pages: |
2317-29 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hu MG |
Year: |
2009 |
Journal: |
Cancer Res |
Title: |
A requirement for cyclin-dependent kinase 6 in thymocyte development and tumorigenesis. |
Volume: |
69 |
Issue: |
3 |
Pages: |
810-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Alejandro EU |
Year: |
2015 |
Journal: |
Cell Rep |
Title: |
Disruption of O-linked N-Acetylglucosamine Signaling Induces ER Stress and β Cell Failure. |
Volume: |
13 |
Issue: |
11 |
Pages: |
2527-2538 |
|
•
•
•
•
•
|
Genotype |
Symbol: |
Tg(CAG-lacZ,-Akt1*,-EGFP)56Ebm/? Tg(Fabp7-cre,-lacZ)3Gtm/? |
Background: |
involves: 129S1/Sv * 129X1/SvJ * C57BL/6 * CBA |
Zygosity: |
cn |
Has Mutant Allele: |
true |
|
•
•
•
•
•
|
Publication |
First Author: |
Hosokawa H |
Year: |
2016 |
Journal: |
Nat Commun |
Title: |
Akt1-mediated Gata3 phosphorylation controls the repression of IFNγ in memory-type Th2 cells. |
Volume: |
7 |
|
Pages: |
11289 |
|
•
•
•
•
•
|
Publication |
First Author: |
Dillon RL |
Year: |
2010 |
Journal: |
Cancer Res |
Title: |
Distinct biological roles for the akt family in mammary tumor progression. |
Volume: |
70 |
Issue: |
11 |
Pages: |
4260-4 |
|
•
•
•
•
•
|
Publication |
First Author: |
Majumder PK |
Year: |
2008 |
Journal: |
Cancer Cell |
Title: |
A prostatic intraepithelial neoplasia-dependent p27 Kip1 checkpoint induces senescence and inhibits cell proliferation and cancer progression. |
Volume: |
14 |
Issue: |
2 |
Pages: |
146-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Braccini L |
Year: |
2015 |
Journal: |
Nat Commun |
Title: |
PI3K-C2γ is a Rab5 effector selectively controlling endosomal Akt2 activation downstream of insulin signalling. |
Volume: |
6 |
|
Pages: |
7400 |
|
•
•
•
•
•
|
Publication |
First Author: |
Li Z |
Year: |
2010 |
Journal: |
Cell |
Title: |
Caspase-3 activation via mitochondria is required for long-term depression and AMPA receptor internalization. |
Volume: |
141 |
Issue: |
5 |
Pages: |
859-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shiojima I |
Year: |
2005 |
Journal: |
J Clin Invest |
Title: |
Disruption of coordinated cardiac hypertrophy and angiogenesis contributes to the transition to heart failure. |
Volume: |
115 |
Issue: |
8 |
Pages: |
2108-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Piovan E |
Year: |
2013 |
Journal: |
Cancer Cell |
Title: |
Direct reversal of glucocorticoid resistance by AKT inhibition in acute lymphoblastic leukemia. |
Volume: |
24 |
Issue: |
6 |
Pages: |
766-76 |
|
•
•
•
•
•
|
Publication |
First Author: |
Majumder PK |
Year: |
2004 |
Journal: |
Nat Med |
Title: |
mTOR inhibition reverses Akt-dependent prostate intraepithelial neoplasia through regulation of apoptotic and HIF-1-dependent pathways. |
Volume: |
10 |
Issue: |
6 |
Pages: |
594-601 |
|
•
•
•
•
•
|
Publication |
First Author: |
Miao L |
Year: |
2016 |
Journal: |
Elife |
Title: |
mTORC1 is necessary but mTORC2 and GSK3β are inhibitory for AKT3-induced axon regeneration in the central nervous system. |
Volume: |
5 |
|
Pages: |
e14908 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ema M |
Year: |
2008 |
Journal: |
Cell Stem Cell |
Title: |
Krüppel-like factor 5 is essential for blastocyst development and the normal self-renewal of mouse ESCs. |
Volume: |
3 |
Issue: |
5 |
Pages: |
555-67 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sharma M |
Year: |
2018 |
Journal: |
Development |
Title: |
Cyclical expression of GDNF is required for spermatogonial stem cell homeostasis. |
Volume: |
145 |
Issue: |
5 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Hodgkinson CP |
Year: |
2013 |
Journal: |
Stem Cells |
Title: |
Abi3bp is a multifunctional autocrine/paracrine factor that regulates mesenchymal stem cell biology. |
Volume: |
31 |
Issue: |
8 |
Pages: |
1669-82 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hashimoto H |
Year: |
2019 |
Journal: |
Cell Stem Cell |
Title: |
Cardiac Reprogramming Factors Synergistically Activate Genome-wide Cardiogenic Stage-Specific Enhancers. |
Volume: |
25 |
Issue: |
1 |
Pages: |
69-86.e5 |
|
•
•
•
•
•
|
Publication |
First Author: |
Lv K |
Year: |
2015 |
Journal: |
J Neurosci |
Title: |
Trip6 promotes dendritic morphogenesis through dephosphorylated GRIP1-dependent myosin VI and F-actin organization. |
Volume: |
35 |
Issue: |
6 |
Pages: |
2559-71 |
|
•
•
•
•
•
|
Publication |
First Author: |
Vandanmagsar B |
Year: |
2016 |
Journal: |
Cell Rep |
Title: |
Impaired Mitochondrial Fat Oxidation Induces FGF21 in Muscle. |
Volume: |
15 |
Issue: |
8 |
Pages: |
1686-99 |
|
•
•
•
•
•
|
Publication |
First Author: |
Okoro EU |
Year: |
2016 |
Journal: |
Biochem Biophys Res Commun |
Title: |
Akt isoform-dependent regulation of ATP-Binding cassette A1 expression by apolipoprotein E. |
Volume: |
477 |
Issue: |
1 |
Pages: |
123-8 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kanatsu-Shinohara M |
Year: |
2016 |
Journal: |
Genes Dev |
Title: |
Myc/Mycn-mediated glycolysis enhances mouse spermatogonial stem cell self-renewal. |
Volume: |
30 |
Issue: |
23 |
Pages: |
2637-2648 |
|
•
•
•
•
•
|
Publication |
First Author: |
Valentino E |
Year: |
2017 |
Journal: |
Proc Natl Acad Sci U S A |
Title: |
Mutant p53 potentiates the oncogenic effects of insulin by inhibiting the tumor suppressor DAB2IP. |
Volume: |
114 |
Issue: |
29 |
Pages: |
7623-7628 |
|
•
•
•
•
•
|
Publication |
First Author: |
Malanga D |
Year: |
2016 |
Journal: |
PLoS One |
Title: |
AKT1E¹⁷K Is Oncogenic in Mouse Lung and Cooperates with Chemical Carcinogens in Inducing Lung Cancer. |
Volume: |
11 |
Issue: |
2 |
Pages: |
e0147334 |
|
•
•
•
•
•
|
Publication |
First Author: |
Chen K |
Year: |
2023 |
Journal: |
Exp Mol Med |
Title: |
CircFam190a: a critical positive regulator of osteoclast differentiation via enhancement of the AKT1/HSP90β complex. |
Volume: |
55 |
Issue: |
9 |
Pages: |
2051-2066 |
|
•
•
•
•
•
|
Publication |
First Author: |
Zhou Y |
Year: |
2020 |
Journal: |
Sci Transl Med |
Title: |
PBX1 expression in uterine natural killer cells drives fetal growth. |
Volume: |
12 |
Issue: |
537 |
|
|
•
•
•
•
•
|
Publication |
First Author: |
Liu X |
Year: |
2016 |
Journal: |
Genes Dev |
Title: |
Genetic ablation of Smoothened in pancreatic fibroblasts increases acinar-ductal metaplasia. |
Volume: |
30 |
Issue: |
17 |
Pages: |
1943-55 |
|
•
•
•
•
•
|
Publication |
First Author: |
Tran CW |
Year: |
2017 |
Journal: |
J Immunol |
Title: |
Glycogen Synthase Kinase-3 Modulates Cbl-b and Constrains T Cell Activation. |
Volume: |
199 |
Issue: |
12 |
Pages: |
4056-4065 |
|
•
•
•
•
•
|
Publication |
First Author: |
Rao S |
Year: |
2007 |
Journal: |
Development |
Title: |
Obligatory participation of macrophages in an angiopoietin 2-mediated cell death switch. |
Volume: |
134 |
Issue: |
24 |
Pages: |
4449-58 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yang K |
Year: |
2011 |
Journal: |
Nat Immunol |
Title: |
The tumor suppressor Tsc1 enforces quiescence of naive T cells to promote immune homeostasis and function. |
Volume: |
12 |
Issue: |
9 |
Pages: |
888-97 |
|
•
•
•
•
•
|
Publication |
First Author: |
Wright GL |
Year: |
2008 |
Journal: |
FASEB J |
Title: |
VEGF stimulation of mitochondrial biogenesis: requirement of AKT3 kinase. |
Volume: |
22 |
Issue: |
9 |
Pages: |
3264-75 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu D |
Year: |
2010 |
Journal: |
J Biol Chem |
Title: |
Regulation of PTEN stability and activity by Plk3. |
Volume: |
285 |
Issue: |
51 |
Pages: |
39935-42 |
|
•
•
•
•
•
|
Publication |
First Author: |
Gu J |
Year: |
2018 |
Journal: |
Diabetes |
Title: |
Metallothionein Preserves Akt2 Activity and Cardiac Function via Inhibiting TRB3 in Diabetic Hearts. |
Volume: |
67 |
Issue: |
3 |
Pages: |
507-517 |
|
•
•
•
•
•
|
Publication |
First Author: |
Molina SA |
Year: |
2017 |
Journal: |
Am J Physiol Lung Cell Mol Physiol |
Title: |
Insulin signaling via the PI3-kinase/Akt pathway regulates airway glucose uptake and barrier function in a CFTR-dependent manner. |
Volume: |
312 |
Issue: |
5 |
Pages: |
L688-L702 |
|
•
•
•
•
•
|
Publication |
First Author: |
Esquiliano DR |
Year: |
2009 |
Journal: |
Placenta |
Title: |
Placental glycogen stores are increased in mice with H19 null mutations but not in those with insulin or IGF type 1 receptor mutations. |
Volume: |
30 |
Issue: |
8 |
Pages: |
693-9 |
|
•
•
•
•
•
|
Publication |
First Author: |
Becker M |
Year: |
2010 |
Journal: |
Diabetes |
Title: |
Expression of human chemerin induces insulin resistance in the skeletal muscle but does not affect weight, lipid levels, and atherosclerosis in LDL receptor knockout mice on high-fat diet. |
Volume: |
59 |
Issue: |
11 |
Pages: |
2898-903 |
|
•
•
•
•
•
|
Publication |
First Author: |
Krishna SM |
Year: |
2012 |
Journal: |
Am J Pathol |
Title: |
Fenofibrate increases high-density lipoprotein and sphingosine 1 phosphate concentrations limiting abdominal aortic aneurysm progression in a mouse model. |
Volume: |
181 |
Issue: |
2 |
Pages: |
706-18 |
|
•
•
•
•
•
|
Publication |
First Author: |
Prieto-Bermejo R |
Year: |
2021 |
Journal: |
Haematologica |
Title: |
Cyba-deficient mice display an increase in hematopoietic stem cells and an overproduction of immunoglobulins. |
Volume: |
106 |
Issue: |
1 |
Pages: |
142-153 |
|
•
•
•
•
•
|
Publication |
First Author: |
Xu PZ |
Year: |
2012 |
Journal: |
Oncogene |
Title: |
The effect Akt2 deletion on tumor development in Pten(+/-) mice. |
Volume: |
31 |
Issue: |
4 |
Pages: |
518-26 |
|
•
•
•
•
•
|
Publication |
First Author: |
Shang X |
Year: |
2016 |
Journal: |
J Vasc Res |
Title: |
Differential Regulation of BMAL1, CLOCK, and Endothelial Signaling in the Aortic Arch and Ligated Common Carotid Artery. |
Volume: |
53 |
Issue: |
5-6 |
Pages: |
269-278 |
|
•
•
•
•
•
|
Publication |
First Author: |
Sakamoto K |
Year: |
2009 |
Journal: |
Cancer Res |
Title: |
Targeting janus kinase 2 in Her2/neu-expressing mammary cancer: Implications for cancer prevention and therapy. |
Volume: |
69 |
Issue: |
16 |
Pages: |
6642-50 |
|
•
•
•
•
•
|
Publication |
First Author: |
Castellanos-Martín A |
Year: |
2015 |
Journal: |
Genome Biol |
Title: |
Unraveling heterogeneous susceptibility and the evolution of breast cancer using a systems biology approach. |
Volume: |
16 |
Issue: |
1 |
Pages: |
40 |
|
•
•
•
•
•
|
Publication |
First Author: |
Hollander MC |
Year: |
2011 |
Journal: |
Carcinogenesis |
Title: |
A Cyp2a polymorphism predicts susceptibility to NNK-induced lung tumorigenesis in mice. |
Volume: |
32 |
Issue: |
8 |
Pages: |
1279-84 |
|
•
•
•
•
•
|
Publication |
First Author: |
Saji M |
Year: |
2020 |
Journal: |
Sci Rep |
Title: |
Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model. |
Volume: |
10 |
Issue: |
1 |
Pages: |
18316 |
|
•
•
•
•
•
|
Publication |
First Author: |
Kim CS |
Year: |
2005 |
Journal: |
Endocrinology |
Title: |
AKT activation promotes metastasis in a mouse model of follicular thyroid carcinoma. |
Volume: |
146 |
Issue: |
10 |
Pages: |
4456-63 |
|
•
•
•
•
•
|
Publication |
First Author: |
Bauerfeld CP |
Year: |
2012 |
Journal: |
J Immunol |
Title: |
TLR4-mediated AKT activation is MyD88/TRIF dependent and critical for induction of oxidative phosphorylation and mitochondrial transcription factor A in murine macrophages. |
Volume: |
188 |
Issue: |
6 |
Pages: |
2847-57 |
|
•
•
•
•
•
|
Publication |
First Author: |
McCurdy CE |
Year: |
2005 |
Journal: |
Diabetes |
Title: |
Akt2 is essential for the full effect of calorie restriction on insulin-stimulated glucose uptake in skeletal muscle. |
Volume: |
54 |
Issue: |
5 |
Pages: |
1349-56 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yamaguchi N |
Year: |
2011 |
Journal: |
Am J Physiol Heart Circ Physiol |
Title: |
Dysfunctional ryanodine receptor and cardiac hypertrophy: role of signaling molecules. |
Volume: |
300 |
Issue: |
6 |
Pages: |
H2187-95 |
|
•
•
•
•
•
|
Publication |
First Author: |
Ye Q |
Year: |
2023 |
Journal: |
Nat Commun |
Title: |
Deficiency of gluconeogenic enzyme PCK1 promotes metabolic-associated fatty liver disease through PI3K/AKT/PDGF axis activation in male mice. |
Volume: |
14 |
Issue: |
1 |
Pages: |
1402 |
|
•
•
•
•
•
|
Publication |
First Author: |
Meyer NJ |
Year: |
2009 |
Journal: |
FASEB J |
Title: |
GADD45a is a novel candidate gene in inflammatory lung injury via influences on Akt signaling. |
Volume: |
23 |
Issue: |
5 |
Pages: |
1325-37 |
|
•
•
•
•
•
|
Publication |
First Author: |
Yoo HS |
Year: |
2023 |
Journal: |
J Biol Chem |
Title: |
Cyp26a1 supports postnatal retinoic acid homeostasis and glucoregulatory control. |
Volume: |
299 |
Issue: |
5 |
Pages: |
104669 |
|
•
•
•
•
•
|